CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that John J. Wallace has been appointed to its Board of Directors. With this appointment, ZOLL filled a vacancy on its Board of Directors, which now constitutes seven members. Mr. Wallace is Chief Operating Officer and a member of the Board of Directors of Nova Biomedical Corporation, a Waltham, MA–based privately held company engaged in the development, marketing and manufacturing of proprietary blood diagnostic products, consumer healthcare diabetes products, and medical devices. Mr. Wallace also serves as a director and member of the Audit Committee of Vision Sciences, Inc. (NASDAQ: VSCI), a maker of innovative products for flexible endoscopy. He also is a director of several private organizations.
